intertest

Inclusion criteria were as follows: (i) newly diagnosed type 2 diabetes or type 2 diabetics who were inadequately controlled with diet and exercise or had taken oral antidiabetic medication irregularly (treatment duration shorter than 6 months) and had stopped treatment for more than 1 month; (ii) two consecutive FBG tests in 1 week with a level of 8.0–13.5 mmol/L and an intertest difference of <1.8 mmol/L; and (iii) male, aged 18–75 years, with a body mass index (BMI) of ≤40 kg/m 2 .

2015 January 16, Long Wong et al., “Effects of sulfonylurea as initial treatment on testosterone of middle-aged men with type 2 diabetes: A 16-week, pilot study”, in Journal of Diabetes Investigation, volume 6, →DOI

Despite its proven value as a screening tool, the BeLT, like most cell culture–radiolabel incorporation assays, is associated with some intratest, intertest, and interlaboratory variability and provides only a semiquantitative estimate of T cell activity, even when we optimize the methodology. Further methodologic refinements may enhance the test's reliability and predictive value.

1994, Lee S. Newman, “Beryllium lung disease: the role of cell-mediated immunity in pathogenesis”, in Jack H. Dean, Michael I. Luster, Albert E. Munson, Ian Kimber, editors, Immunotoxicology and Immunopharmacology (Target Organ Toxicology Series), 2nd edition, →ISBN, page 389